A team from the George Washington University (GW) Cancer Center has been approved for a $300,000 funding award through the Eugene Washington PCORI Engagement Awards (Engagement Awards) program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI).
Cancer
High exposure to radio frequency radiation associated with cancer in male rats
NTP releases final reports on rat and mouse studies of radio frequency radiation like that used in 2G and 3G cell phone technologies. The National Toxicology Program (NTP) concluded there is clear evidence that male rats exposed to high levels… Read More ›
WHO kicks off global initiative to treat children with cancer
WHO has announced a new Global Initiative for Childhood Cancer – with the aim of reaching at least a 60% survival rate for children with cancer by 2030, thereby saving an additional one million lives.
Harmful use of alcohol kills more than 3 million people each year, most of them men
More than 3 million people died as a result of harmful use of alcohol in 2016, according a report released by the World Health Organization (WHO).
Fecal microbiota transplantation helps restore beneficial bacteria in cancer patients
Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation.
Study: For healthiest diet, eat moderate amount of carbs
“Too much and too little carbohydrate can be harmful but what counts most is the type of fat, protein, and carbohydrate,” said study co-author Walter Willett, professor of epidemiology and nutrition at Harvard Chan School.
A team at the GW Cancer Center will develop a model to study the COMPASS complex in pancreatic cancer and possible targeted therapies
Researchers have found that “squamous-like” pancreatic cancer, a subtype that impacts 15-20 percent of patients, is driven by deregulation of epigenetic mechanisms, resulting in the loss of cell identity and development of highly aggressive and metastatic tumors.